Researcher Profiles

Return to member profile

Sung Kim, MD

Publications since 2011

Jabbour, S. K. Kim, S. Haider, S. A. Xu, X. Wu, A. Surakanti, S. Aisner, J. Langenfeld, J. Yue, N. J. Haffty, B. G. Zou, W. Reduction in Tumor Volume by Cone Beam Computed Tomography Predicts Overall Survival in Non-Small Cell Lung Cancer Treated With Chemoradiation Therapy. Int J Radiat Oncol Biol Phys, 92:627-633, . (PMID: 26068495)

Lu-Yao, G. L. Kim, S. Moore, D. F. Shih, W. Lin, Y. DiPaola, R. S. Shen, S. Zietman, A. Yao, S. L. Primary radiotherapy vs conservative management for localized prostate cancer-a population-based study. Prostate Cancer Prostatic Dis, In process, . (PMID: 26101187)

Kang, J. H. Ha, Y. S. Kim, S. Yu, J. Patel, N. Parihar, J. S. Salmasi, A. H. Kim, W. J. Kim, I. Y. Concern for overtreatment using the AUA/ASTRO guideline on adjuvant radiotherapy after radical prostatectomy. BMC Urol, 14:30, . (PMID: 24708639, PMCID: PMC4005471)

Shao, Y. H. Kim, S. Moore, D. F. Shih, W. Lin, Y. Stein, M. Kim, I. Y. Lu-Yao, G. L. Cancer-specific Survival After Metastasis Following Primary Radical Prostatectomy Compared with Radiation Therapy in Prostate Cancer Patients: Results of a Population-based, Propensity Score-Matched Analysis. Eur Urol, In process, . (PMID: 23759328)

Zhang, M. Qin, S. Chen, T. Kim, S. Jabbour, S. Haffty, B. Yue, N. J. A Clinical Objective IMRT QA Method Based on Portal Dosimetry and Electronic Portal Imager Device (EPID) Measurement. Technol Cancer Res Treat, 12:145-150, . (PMID: 23289479)

Kim, S. Moore, D. F. Shih, W. Lin, Y. Li, H. Shao, Y. H. Shen, S. Lu-Yao, G. L. Severe Genitourinary Toxicity Following Radiation Therapy for Prostate Cancer-How Long Does it Last? J Urol, 189:116-121, . (PMID: 23164376)

Qin, S. Zhang, M. Kim, S. Chen, T. Kim, L. H. Haffty, B. G. Yue, N. J. A systematic approach to statistical analysis in dosimetry and patient-specific IMRT plan verification measurements. Radiat Oncol, 8:225, . (PMID: 24074185, PMCID: PMC3852372)

Yue, N. J. Patel, A. N. Haffty, B. G. Kim, S. Efficacy of fiducial marker-based image-guided radiation therapy in prostate tomotherapy and potential dose coverage improvement using a patient positioning optimization method. Pract Radiat Oncol, 2:138-144, . (PMID: 24674089)

Chowdhury, N. Toth, R. Chappelow, J. Kim, S. Motwani, S. Punekar, S. Lin, H. Both, S. Vapiwala, N. Hahn, S. Madabhushi, A. Concurrent segmentation of the prostate on MRI and CT via linked statistical shape models for radiotherapy planning. Med Phys, 39:2214-2228, . (PMID: 22482643, PMCID: PMC3337664)

Patel, A. N. Mehnert, J. M. Kim, S. Treatment of recurrent metastatic head and neck cancer: focus on cetuximab. Clin Med Insights Ear Nose Throat, 5:1-16, . (PMID: 24179404, PMCID: PMC3791949)

Kim, S. Shen, S. Moore, D. F. Shih, W. Lin, Y. Li, H. Dolan, M. Shao, Y. H. Lu-Yao, G. L. Late gastrointestinal toxicities following radiation therapy for prostate cancer. Eur Urol, 60:908-916, . (PMID: 21684064, PMCID: PMC3185133)

Kim, Y. J. Yoon, H. Y. Kim, S. K. Kim, Y. W. Kim, E. J. Kim, I. Y. Kim, W. J. EFEMP1 as a novel DNA methylation marker for prostate cancer: array-based DNA methylation and expression profiling. Clin Cancer Res, 17:4523-4530, . (PMID: 21571867)

Raldow, A. Hamstra, D. A. Kim, S. N. Yu, J. B. Adjuvant radiotherapy after radical prostatectomy: evidence and analysis. Cancer Treat Rev, 37:89-96, . (PMID: 20667660)

Kim, S. Eleff, M. Nicolaou, N. Cetuximab as primary treatment for cutaneous squamous cell carcinoma to the neck. Head Neck, 33:286-288, . (PMID: 19953623)